SHARES: TAKING STOCK

Monday 26 February 1996 19:02 EST

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

r Antonov, with a new automatic transmission system, motored 13p to 106p as it heeded market complaints about a lack of information about its progress. It said it had inked two Far East deals - a production agreement with an unidentified Asian group and a consultancy with a Japanese car producer, thought to be Honda.

The market expects more deals soon. The group came to market through a share placing at 40p last year on the old 4.2 market. It is now traded on AIM.

r Jim Keir, ex-Amersham International, has been accorded a rapturous welcome since he became chairman of Biotrace International, the health- care group, less than a fortnight ago. The shares were 38.5p when he arrived. Yesterday they gained a further 10p to 64p.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

SHARES: TAKING STOCK

Join our commenting forum

Thank you for registering